Keywords
How to Cite
Abstract
The ameloblastoma is one of the most agressive and localy destructive benign tumors of the human body, capable of producing enormous deformations of the face in a short period of time. In its classification the unicystic variant is consider less agresive and allows a conservative treatment. We present a case of 20 years old female patient, with a unicystic ameloblastoma with a granular cells variant, which was managed in a conservative way, with a two month decompression and a posterior enucleation, with a one year follow up. This treatment is less morbid than the surgical resection with safety margins, avoiding big stetical and functional defects.
Neville B, Damm DD, Allen CM, Bouquot
JE. Oral and maxillofacial pathology.
rd ed. Vol. 1. Philadelphia:
Saunders-Elsevier; 2008.
Motahhary P, Etebarian A, Asareh F.
Granular cell type of a unicystic ameloblastoma:
An unusual case and review of
the literature. J Oral Maxillofac Pathol
JOMFP. 2014 May;18(2):331.
Robinson L, Martinez MG. Unicystic
ameloblastoma: a prognostically distinct
entity. Cancer. 1977 Nov;40(5):2278-85.
Nikolaos G. Nikitakis, Tzerbos F, Triantafyllou
K, Papadimas C, Sklavounou A.
Granular cell ameloblastoma: an unusual
histological subtype report and review of
literature. J Oral Maxillofac Res [Internet].
Jan 1 [cited 2016 Mar 28];1(4).
Disponible en: http://www.ncbi.nlm.nih.
gov/pmc/articles/PMC3886069/
Philipsen HP, Reichart PA. Unicystic
ameloblastoma: A review of 193 cases
from the literature. Oral Oncol. 1998
Sep;34(5):317-25.
Larsson A, Almerén H. Ameloblastoma
of the jaws: An analysis of a consecutive
series of all cases reported to the Swedish
Cancer Registry during 1958-1971.
Acta Pathol Microbiol Scand [A]. 1978
Sep;86A(5):337-49.
Koneru A, Hallikeri K, Nellithady GS,
Krishnapillai R, Prabhu S. Immunohistochemical
expression of calretinin in ameloblastoma, adenomatoid odontogenic
tumor, and keratocystic odontogenic
tumor: A comparative study. Appl Immunohistochem
Mol Morphol AIMM Off
Publ Soc Appl Immunohistochem. 2014
Dec;22(10):762-7.
Ghandhi D, Ayoub AF, Pogrel MA,
MacDonald G, Brocklebank LM, Moos
KF. Ameloblastoma: a surgeon’s dilemma.
J Oral Maxillofac Surg Off J
Am Assoc Oral Maxillofac Surg. 2006
Jul;64(7):1010-4.
Carlson ER, Marx RE. The ameloblastoma:
primary, curative surgical management.
J Oral Maxillofac Surg Off J
Am Assoc Oral Maxillofac Surg. 2006
Mar;64(3):484-94.
Prasad K, Lalitha RM, Ranganath K,
Srikar MV, Dexith J, Sagar P, et al. Unicystic
ameloblastoma, a distinct clinical
entity with favorable response to decompression:
Our experience of 5 cases. J
Oral Maxillofac Surg Med Pathol. 2013
Oct;25(4):328-32.
Lau SL, Samman N. Recurrence related
to treatment modalities of unicystic ameloblastoma:
a systematic review. Int J Oral
Maxillofac Surg. 2006 Aug;35(8):681-90.
Nakamura N, Higuchi Y, Tashiro H,
Ohishi M. Marsupialization of cystic
ameloblastoma: a clinical and histopathologic
study of the growth characteristics
before and after marsupialization. J Oral
Maxillofac Surg Off J Am Assoc Oral
Maxillofac Surg. 1995 Jul;53(7):748-54;
discussion 755-6.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.